Risk factors for nonadherence with pap testing in HIV-infected women

Journal of Women's Health

Volumn 20, Issue 11, 2011, Pages 1635-1643

  Baranoski, Amy S ^a   Horsburgh, C Robert ^a,b   Cupples, L Adrienne ^b   Aschengrau, Ann ^b   Stier, Elizabeth A ^c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CD4 LYMPHOCYTE COUNT; CITIZENSHIP; COHORT ANALYSIS; CONTROLLED STUDY; DRUG ABUSE; FEMALE; FOLLOW UP; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LANGUAGE; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PATIENT COMPLIANCE; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; UNEMPLOYMENT; UNITED STATES; URBAN AREA;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; BOSTON; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; RISK FACTORS; URBAN POPULATION; UTERINE CERVICAL DYSPLASIA; VAGINAL SMEARS; YOUNG ADULT;

EID: 81155125690     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2010.2465     Document Type: Article

References (38)

1. Kitchener HC, Castle PE, Cox JT. Achievements and limitations of cervical cytology screening. Vaccine 2006;24 (Suppl 3):63-70.
2. American College of Obstetricians and Gynecologists. Committee on Practice Bulletins. ACOG practice bulletin: Clinical management guidelines for obstetrician-gynecologists. No. 45. Obstet Gynecol 2003;102:417-427.
3. Six C, Heard I, Bergeron C, et al. Comparative prevalence, incidence and short-term prognosis of cervical squamous intraepithelial lesions amongst HIV-positive and HIV-negative women. AIDS 1998;12:1047-1056.
4. Wright TC Jr, Ellerbrock TV, Chiasson MA, Van Deventer N, Sun XW, and the New York Cervical Disease Study. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: Prevalence, risk factors, and validity of Papanicolaou smears. Obstet Gynecol 1994;84: 591-597.
5. Ellerbrock TV, Chiasson MA, Bush TJ, et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 2000;283:1031-1037.
6. Massad LS, Seaberg EC, Wright RL, et al. Squamous cervical lesions in women with human immunodeficiency virus. Obstet Gynecol 2008;111:1388-1393.
7. Duerr A, Paramsothy P, Jamieson DJ, et al. Effect of HIV infection on atypical squamous cells of undetermined significance. Clin Infect Dis 2006;42:855-861.
8. Duerr A, Kieke B, Warren D, et al. Human papillomavirus-associated cervical cytologic abnormalities among women with or at risk of infection with human immunodeficiency virus. Am J Obstet Gynecol 2001;184:584-590.
9. Franceschi S, Jaffe H. Cervical cancer screening of women living with HIV infection: A must in the era of antiretroviral therapy. Clin Infect Dis 2007;45:510-513.
10. Kaplan JE, Benson C, Holmes KK, et al. Guidelines for the prevention and treatment of opportunistic infections among HIV-infected adults and adolescents. Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR 2009;58(RR04):1-198.
11. A guide to the clinical care of women with HIV/AIDS 2005 ed. U.S. Department of Health and Human Services: Health Resources and Services Administration 2005. Available at hab.hrsa.gov Accessed May 4, 2010.
12. NY State HIV Clinical Guidelines. HIV clinical resource: Gynecological care 2009. Available at: www.hivguideline-s.org Accessed June 18, 2009.
13. Oster A, Sullivan PS, Blair JM. Prevalence of cervical cancer screening of HIV-infected women in the United States. J Acquir Immune Defic Syndr 2009;51:430-436.
14. Stein MD, Cunningham WE, Nakazono T, et al. Screening for cervical cancer in HIV-infected women receiving care in the United States. J Acquir Immune Defic Syndr 2001;27:463-466.
15. Hewitt M, Devesa SS, Breen N. Cervical cancer screening among U.S. women: Analyses of the 2000 National Health Interview Survey. Prev Med 2004;39:270-278.
16. Blackwell DL, Martinez ME, Gentleman JF. Women's compliance with public health guidelines for mammograms and Pap tests in Canada and the United States. Womens Health Issues 2008;18:85-99.
17. Datta GD, Colditz GA, Kawachi I, Subramanian SV, Palmer JR, Rosenberg L. Individual-, neighborhood- and state-level socioeconomic predictors of cervical carcinoma screening among U.S. black women. Cancer 2006;106:664-669.
18. Sheinfeld Gorin S, Heck JE. Cancer screening among Latino subgroups in the United States. Prev Med 2005;40:515-526.
19. Peterson NB, Murff HJ, Cui Y, Hargreaves M, Fowke JH. Papanicolaou testing among women in the southern United States. J Womens Health 2008;17:939-946.
20. Hall HI, Uhler RJ, Coughlin SS, Miller DS. Breast and cervical cancer screening among Appalachian women. Cancer Epidemiol Biomarkers Prev 2002;11:137-142.
21. Coughlin SS, King J, Richards TB, Ekwueme DU. Cervical cancer screening among women in metropolitan areas of the United States by individual-level and area-based measures of socioeconomic status, 2000 to 2002. Cancer Epidemiol Biomarkers Prev 2006;15:2154-2159.
22. Ferrante JM, Chen PH, Crabtree BF, Wartenberg D. Cancer screening in women: Body mass index and adherence to physician recommendations. Am J Prev Med 2007;32: 525-531.
23. Selvin E, Brett KM. Breast and cervical cancer screening: Sociodemographic predictors among white, black, and Hispanic women. Am J Public Health 2003;93:618-623.
24. Grange G, Malvy D, Lancon F, Gaudin AF, El Hasnaoui A. Factors associated with regular cervical cancer screening. Int J Gynaecol Obstet 2008;102:28-33.
25. Dal Maso L, Franceschi S, Lise M, et al. Self-reported history of Pap-smear in HIV-positive women in Northern Italy: A cross-sectional study. BMC Cancer 2010;10:310.
26. Keiser O, Martinez de Tejada B, Wunder D, et al. Frequency of gynecologic follow-up and cervical cancer screening in the Swiss HIV cohort study. J Acquir Immune Defic Syndr 2006;43:550-555.
27. Tello MA, Jenckes M, Gaver J, Anderson JR, Moore RD, Chander G. Barriers to recommended gynecologic care in an urban United States HIV clinic. J Womens Health 2010;19: 1511-1518.
28. Tello MA, Yeh HC, Keller JM, Beach MC, Anderson JR, Moore RD. HIV women's health: A study of gynecological health service utilization in a U.S. urban clinic population. J Womens Health 2008;17:1609-1614.
29. Rahangdale L, Sarnquist C, Yavari A, Blumenthal P, Israelski D. Frequency of cervical cancer and breast cancer screening in HIV-infected women in a county-based HIV clinic in the western United States. J Womens Health 2010;19:709-712.
30. Shah S, Montgomery H, Smith C, et al. Cervical screening in HIV-positive women: Characteristics of those who default and attitudes towards screening. HIV Med 2006;7:46-52.
31. Johnston G. Repeated measures analysis with discrete data using the SAS system. Available at support.sas.com/rnd/app/papers/gee.pdf Accessed November 6, 2009.
32. Rothman KJ, Greenland S, Lash TL. Modern epidemiology, 3rd ed. Philadelphia: Wolters Kluwer Health, Lippincott Williams & Wilkins, 2008:129-134.
33. Howard M, Agarwal G, Lytwyn A. Accuracy of self-reports of Pap and mammography screening compared to medical record: A meta-analysis. Cancer Causes Control 2009;20: 1-13.
34. Tsui J, Saraiya M, Thompson T, Dey A, Richardson L. Cervical cancer screening among foreign-born women by birthplace and duration in the United States. J Womens Health 2007;16:1447-1457.
35. Behbakht K, Lynch A, Teal S, Degeest K, Massad S. Social and cultural barriers to Papanicolaou test screening in an urban population. Obstet Gynecol 2004;104:1355-1361.
36. Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, et al. Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Gynecol Oncol 2006;103:1017-1022.
37. Garcia F, de Lazzari E, Plana M, et al. Long-term CD4 + T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count. J Acquir Immune Defic Syndr 2004;36:702-713.
38. Cejtin HE, Komaroff E, Massad LS, et al. Adherence to col-poscopy among women with HIV infection. J Acquir Immune Defic Syndr 1999;22:247-252.